BLK vs COLL · P/E 27, rev $24.22B vs P/E 17, rev $181.9M
BlackRock Inc (BLK) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the BLK and COLL stock pages for the full models.
Not investment advice.